Provided by Tiger Trade Technology Pte. Ltd.

Centessa Pharmaceuticals plc

39.70
+0.13000.33%
Post-market: 39.700.00000.00%16:10 EDT
Volume:876.49K
Turnover:34.80M
Market Cap:6.14B
PE:-27.19
High:39.79
Open:39.51
Low:39.51
Close:39.57
52wk High:40.26
52wk Low:10.95
Shares:154.57M
Float Shares:89.33M
Volume Ratio:0.53
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4600
EPS(LYR):-1.4600
ROE:-42.55%
ROA:-20.53%
PB:11.65
PE(LYR):-27.19

Loading ...

Centessa Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 29

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Centessa Pharmaceuticals (CNTA) and Perspective Therapeutics (CATX)

TIPRANKS
·
Apr 20

Wells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35

MT Newswires Live
·
Apr 20

Centessa downgraded to Equal Weight from Overweight at Wells Fargo

TIPRANKS
·
Apr 20

Centessa Pharmaceuticals Plc : Truist Securities Cuts to Hold From Buy

THOMSON REUTERS
·
Apr 13

Centessa downgraded to Hold from Buy at Truist

TIPRANKS
·
Apr 13

The Trader: Biotechs Are a Healthy Growth Bet. Thank M&A and New Drugs. -- Barron's

Dow Jones
·
Apr 04

Centessa Pharmaceuticals Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
Apr 02

Centessa Pharmaceuticals PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Apr 02

Centessa downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Apr 02

Centessa Pharmaceuticals Agrees To Eli Lilly Acquisition At 40% Premium

Benzinga_recent_news
·
Apr 01

Eli Lilly Diversifies from Weight-Loss Drugs to Sleep Disorders with Up to $7.8 Billion Centessa Acquisition

Deep News
·
Apr 01

BUZZ-Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market

Reuters
·
Apr 01

Centessa downgraded to Market Perform from Outperform at LifeSci Capital

TIPRANKS
·
Apr 01

B. Riley Downgrades Centessa Pharmaceuticals to Neutral From Buy, Lifts Price Target to $45 From $42

MT Newswires Live
·
Apr 01

Centessa Pharmaceuticals Plc : Leerink Partners Cuts to Market Perform From Outperform; Raises Target Price to $40 From $36

THOMSON REUTERS
·
Apr 01

Centessa Pharmaceuticals Plc : Stephens Cuts to Equal Weight From Overweight; Raises Target Price to $47 From $35

THOMSON REUTERS
·
Apr 01

Nxera partner Centessa agrees to be acquired by Lilly

Reuters
·
Apr 01

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

Dow Jones
·
Apr 01

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

Dow Jones
·
Apr 01